Share Twitter LinkedIn Facebook Email Leonard Saltz, MD, Executive Director for Clinical Value and Sustainability, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center evaluates the complexities of managing advanced/refractory metastatic colorectal cancer (mCRC).
NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read
KRYSTAL-1: Adagrasib + Cetuximab Promise for KRASG12C Colorectal Cancer – Scott Kopetz, MD [AACR 2024] Colorectal 3 Mins Read
2024 Optimistic Advances in Colorectal Cancer: New Genetic Discoveries & Dancing Colorectal 5 Mins Read